NYSE - Delayed Quote USD

Envista Holdings Corporation (NVST)

18.53 -0.60 (-3.14%)
At close: May 17 at 4:00 PM EDT
18.89 +0.36 (+1.94%)
After hours: May 17 at 7:22 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stephen Keller VP of Investor Relations & Principal Financial Officer 453.73k -- 1975
Mr. Mark E. Nance Senior VP, General Counsel & Secretary 592.96k -- 1969
Mr. Eric Conley Senior VP & President of Orthodontics 766.86k -- 1975
Mr. Paul A. Keel CEO & Director -- -- 1970
Mr. Faez Kaabi VP, Chief Accounting Officer & Corporate Controller -- -- 1968
Mr. Andrew Chen Chief Information Officer -- -- --
Paul Sumilas Chief Compliance Officer -- -- --
Mr. Mischa M. Reis Senior Vice President of Strategy & Corporate Development -- -- 1973
Mr. Suraj Satpathy Chief Human Resources officer -- -- --
Mr. Filippo Impieri Senior Vice President of Emerging Markets -- -- --

Envista Holdings Corporation

Building E
200 South Kraemer Boulevard
Brea, CA 92821-6208
United States
714 817 7000 https://envistaco.com
Sector: 
Healthcare
Full Time Employees: 
12,800

Description

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Corporate Governance

Envista Holdings Corporation’s ISS Governance QualityScore as of May 1, 2024 is 4. The pillar scores are Audit: 5; Board: 4; Shareholder Rights: 5; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 31, 2024 at 10:59 AM UTC - August 5, 2024 at 12:00 PM UTC

Envista Holdings Corporation Earnings Date

Recent Events

May 1, 2024 at 9:00 PM UTC

Q1 2024 Earnings Call

May 1, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 8, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

March 29, 2024 at 12:00 AM UTC

PRE 14A: Proxy Statements

March 28, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 15, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 8, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

February 7, 2024 at 10:00 PM UTC

Q4 2023 Earnings Call

Related Tickers